Type I and type II T-cell profiles in aplastic anemia and refractory anemia

被引:6
|
作者
Tsuda, H [1 ]
Yamasaki, H [1 ]
机构
[1] Kumamoto City Hosp, Div Clin Hematol & Immunol, Kumamoto 8628505, Japan
关键词
pathogenesis; immune mechanism; T-cell subset; aplastic anemia; myelodysplastic syndrome; refractory anemia;
D O I
10.1002/1096-8652(200008)64:4<271::AID-AJH6>3.0.CO;2-C
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune-mediated suppression of hematopoiesis has been considered the most important mechanism in the development of idiopathic aplastic anemia (AA) and some types of myelodysplastic syndrome (MDS). Using flow cytometric analysis of intracellular cytokine expression at the single-cell level, we analyzed helper-T (Th) and cytotoxic-T (Tc) subsets in patients with AA and MDS of refractory anemia (RA) subtype. The results showed marked increases in the Th1/Th2 ratio and Tc1/Tc2 ratio in both AA and MDS/RA. Overproduction of cytokines inhibitory to hematopoiesis reported so far might be a reflection of imbalanced development of Th and Tc. Determination of the factors that affect Th and Tc profiles may lead to further understanding of immunological states and the development of effective immunotherapy in AA as well as some types of MDS. Am. J. Hematol. 64:271-274, 2000. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:271 / 274
页数:4
相关论文
共 50 条
  • [1] T-Cell type acute lymphoblastic leukemia following cyclosporin a therapy for aplastic anemia
    Hirose, Y
    Masaki, Y
    Ebata, K
    Okada, J
    Kim, CG
    Ogawa, N
    Wano, Y
    Sugai, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 73 (02) : 226 - 229
  • [2] T-Cell Type Acute Lymphoblastic Leukemia Following Cyclosporin A Therapy for Aplastic Anemia
    Yuko Hirose
    Yasufumi Masaki
    Kazumi Ebata
    Jun Okada
    Chang gi Kim
    Noriyoshi Ogawa
    Yuji Wano
    Susumu Sugai
    International Journal of Hematology, 2001, 73 : 226 - 229
  • [3] Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia
    Smith, Julianne N. P.
    Kanwar, Vikramjit S.
    MacNamara, Katherine C.
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [4] T-CELL SUBSETS IN PATIENTS WITH APLASTIC-ANEMIA
    FALCAO, RP
    VOLTARELLI, JC
    BOTTURA, C
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1984, 17 (02) : 151 - 156
  • [5] A proposal to rename and classify aplastic anemia as Myeloaplastic syndrome (MAS) Type I and II
    Venniyoor, A.
    MEDICAL HYPOTHESES, 2010, 74 (06) : 1085 - 1086
  • [6] Aplastic crisis as a complication of congenital dyserythropoietic anemia type II
    Heimpel, H.
    Wilts, H.
    Hirschmann, W. D.
    Hofmann, W. K.
    Siciliano, R. D.
    Steinke, B.
    Wechsler, J. G.
    ACTA HAEMATOLOGICA, 2007, 117 (02) : 115 - 118
  • [7] Enteropathy-Associated T-Cell Lymphoma Type II Complicated by Autoimmune Hemolytic Anemia
    Kato, Aiko
    Takiuchi, Yoko
    Aoki, Kazunari
    Ono, Yuichiro
    Arima, Hiroshi
    Nagano, Seiji
    Tabata, Sumie
    Yanagita, Soshi
    Matsushita, Akiko
    Maruoka, Hayato
    Wada, Masaya
    Imai, Yukihiro
    Ishikawa, Takayuki
    Takahashi, Takayuki
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2011, 51 (02) : 119 - 123
  • [8] OUR EXPERIENCE OF HEMATOPOIETIC CELL TRANSPLANTATION FOR APLASTIC ANEMIA AND PEDIATRIC REFRACTORY ANEMIA
    Mizushima, Yoshitaka
    Arakawa, Yuki
    Mitani, Yuichi
    Oshima, Koichi
    Mori, Makiko
    Fukuoka, Kohei
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S82 - S83
  • [9] Clinical significance of increased PNH-Type cells in the peripheral blood of patients with aplastic anemia and refractory anemia
    Nakao, S
    Wang, HB
    Chuhjo, T
    PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND RELATED DISORDERS: MOLECULAR ASPECTS OF PATHOGENESIS, 2003, : 129 - 137
  • [10] ELTROMBOPAG IN REFRACTORY APLASTIC ANEMIA
    Cagliyan, G. Akgun
    Ozlu, C.
    Bilgir, O.
    Asma, I.
    LEUKEMIA RESEARCH, 2014, 38 : S48 - S49